Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Article
Help in Overcoming Obstacles and Resistance to Therapy
I would like to start off this blog with two stories that happened many years ago.
Array
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Related Videos
Open Label Phase 3 Study of Brilaroxazine for Schizophrenia Shows Efficacy, Tolerability
Developing a Small Molecule With Lithium's Benefits, But Not its Baggage: A Conversation With Jonathan M. Meyer, MD, DLFAPA
Insulin Is an Antidepressant: A Conversation With Roger McIntyre, MD, FRCPC
A Shift in the Way We Think About the Biology of Depression: A Conversation With John H. Krystal, MD
Use of Plasma Levels of Antipsychotics: A Conversation With Jonathan M. Meyer, MD, DLFAPA
Nassir Ghaemi, MD, MPH, Explores SRIs at APA Annual Meeting
Serious Mental Illness, Substance Use Disorders, and Long-Acting Injectables in the Emergency Setting
Exploring New Frontiers in Depression Treatment at the APA Annual Meeting: A Call for Precision Psychiatry
New Research on Addressing Metabolic Issues Associated With Antipsychotics at APA Annual Meeting
Targeting Brain Cortisol: Xanamem Shows Promise in Depression and Alzheimer Disease
Related Content
